First steps towards a new approach to epilepsy treatment

Jun 19, 2008

The most prestigious funding body in the world for epilepsy has financially backed Australian research into new approaches to treat the condition.

The Epilepsy Therapy Project will provide almost US$300,000 over the next two years to a group of researchers from leading Australian institutions including the University of Newcastle.

The group will further develop new ways to treat the one-third of epilepsy patients for whom current treatments do not control their seizures.

Associate Professor Adam McCluskey from the University's School of Environmental andLife Sciences said the new funding would build on recent discoveries involving brain cell communication in sufferers of epilepsy.

"We have already found that compounds designed to block the action of a protein calleddynamin are effective against laboratory models of epilepsy – in these models they appear to block progression of key elements associated with epileptic seizures," Associate Professor McCluskey said.

"Four classes of drugs have been tested and two of these show real potential in stopping epileptic seizures, which is promising news for the one-third of people who don't respond to current treatments."

Approximately one in 120 people have epilepsy, while up to five per cent of the world's population will have a seizure at some time in their lives.

"The funding will allow us to continue clinical development of the new drugs and move towards commercialisation. If all goes to plan a new treatment for epilepsy could beentering clinical trials within the next three to five years," Associate Professor McCluskey said.

Source: Research Australia

Explore further: Have a cold? Don't ask your doctor for antibiotics

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

11 hours ago

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.